rAdV-SFV-E2 is an adenovirus-delivered, alphavirus replicon-vectored vaccine against CSF.
Maternally derived antibodies (MDAs) from rAdV-SFV-E2-immunized sows were evaluated for passive protection.
MDAs were detected in piglets from the sow immunized with 4 × 106 TCID50 rAdV-SFV-E2.
Piglets with MDAs from the immunized sow were fully protected from lethal CSFV challenge.
Piglets with undetectable MDAs from the immunized sow were partially protected.